It has been more than a year since the healthcare joint venture between Amazon, JPMorgan Chase and Berkshire Hathaway was announced. Since then, we haven't heard much — until now. Last week, the venture finally got a name, Haven, and on its new website, the joint venture shared where it will focus within this $8 trillion global industry. And earlier this month, 300 pages of unsealed court documents offered additional clues about Haven’s plans. On this episode of GeekWire's Health Tech podcast, we catch up with health tech entrepreneurs, 98point6 CEO Robbie Cape and Wellpepper CEO Anne Weiler, to get their take on the joint venture's ambitions.

See omnystudio.com/listener for privacy information.

Beth Kolko's superpower may not seem that out of the ordinary. She can't see through walls, but she can see what's wrong with the things we use in everyday life — problems that never occurred to the experts who built them. As the CEO of medical device maker Shift Labs, Kolko has focused that superpower on health care. Specifically, she wants to solve the problems that arise when an industry makes medical devices almost exclusively for patients in hospitals in rich countries and ignores almost everyone else.

See omnystudio.com/listener for privacy information.

On this episode of GeekWire Health Tech, we look at how portable ultrasound devices are changing the medical landscape – building on the technology’s roots in the Seattle region. Ultrasound is going far beyond obstetrics  to allowing physicians to diagnose medical conditions more efficiently -- in the field and the clinic. And increasingly, it’s being used not just for imaging and diagnosis but for actual treatment of disease. Our guests are Mike Bailey, an engineer who focuses on ultrasound research and development at the University of Washington, along with health journalist Kellie Schmitt, who writes about the evolution of ultrasound in a new GeekWire article.

See omnystudio.com/listener for privacy information.

This episode features highlights from a special event, kicking off Season 3 of GeekWire's Health Podcast, on location at Premera Blue Cross, the sponsor of this new season of the show. The discussion sets the stage for the topics we'll be exploring this season, looking at the many ways technology is changing the healthcare landscape. We're joined by Ranjani Ramamurthy, principal physician scientist at Microsoft, who has a background in both medicine and engineering, as an MD and a computer scientist; Oron Afek, CEO and co-founder at healthcare technology startup Vim; and Robbie Cape, CEO and co-founder of startup 98point6, a Seattle-based entrepreneur who sold his previous company, Cozi, to Time Inc. The discussion is kicked off by John Espinola, executive vice president of healthcare services for Premera Blue Cross.

See omnystudio.com/listener for privacy information.

Twenty-one years ago, Claudia Mitchell arrived in a new country to start her doctorate program — with a 4-month old baby in tow. She is now a geneticist, an award-winning entrepreneur and the leader of Universal Cells, which was acquired in January for $100 million. Claudia shares her entrepreneur's journey with us on the season two finale of Health Tech, including the game-changing impact of universal donor cell technology.

See omnystudio.com/listener for privacy information.

In 2000, rotavirus killed more than half a million children every year. Not many people had even heard of the disease. Then an unlikely alliance of international scientists, policymakers, one inexperienced entrepreneur and the richest man in the world teamed up to take it on. We tell the story of what happened on this episode.

See omnystudio.com/listener for privacy information.

Nine years ago, Stephanie Florence was diagnosed with incurable blood cancer. Today, she's cancer-free thanks to a new treatment called CAR T immunotherapy. This treatment is the golden child of cancer research today — but it wasn't always this way. Find out how CAR T went from an underdog to a cancer killer on this episode of Health Tech.

See omnystudio.com/listener for privacy information.

The U.S. healthcare system needs to change. But how? Can the system be 'fixed' the way that Amazon, Berkshire Hathaway and JPMorgan Chase want to fix it with their new healthcare company? What would 'fixing' the system even look like? We explore answers to those questions on this episode of Health Tech. 

See omnystudio.com/listener for privacy information.

Dr. Dan Low wanted to know how his patients were doing on a new drug. Getting the data was so painful, he decided to found his own software company to make it easier. On this episode of Health Tech: Dan's journey from career doctor to startup CEO and back, and what his experience says about the state of healthcare data.

See omnystudio.com/listener for privacy information.

Su-In Lee's father passed away from incurable cancer. Now she's using her expertise in artificial intelligence to help cancer patients find the most effective treatment — based on their genetic data. On this episode, we follow Su-In's story and explore how precision medicine is increasingly using health data, AI and other technologies to fight diseases from cancer to Alzheimer's. 

See omnystudio.com/listener for privacy information.